Global Rituxan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rituxan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy.
Rituxan report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rituxan market is projected to reach US$ 469.8 million in 2029, increasing from US$ 1023 million in 2022, with the CAGR of -10.5% during the period of 2024 to 2029. Demand from Intravenous Use and Subcutaneous Use are the major drivers for the industry.
Rituxan, a monoclonal antibody used for the treatment of various cancers and autoimmune disorders, continues to witness strong demand. Factors such as increasing prevalence of target diseases, growing adoption of targeted therapies, and favorable reimbursement policies contribute to market growth. Key players in the market are investing in research and development to expand the indications of Rituxan and develop biosimilar versions. Additionally, strategic collaborations and partnerships are facilitating market expansion. However, challenges such as the availability of alternative therapies and the high cost of treatment may limit market growth. Overall, the Rituxan market is expected to exhibit positive growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rituxan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg
Intravenous Use
Subcutaneous Use
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rituxan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rituxan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rituxan industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rituxan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rituxan introduction, etc. Rituxan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rituxan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Rituxan report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rituxan market is projected to reach US$ 469.8 million in 2029, increasing from US$ 1023 million in 2022, with the CAGR of -10.5% during the period of 2024 to 2029. Demand from Intravenous Use and Subcutaneous Use are the major drivers for the industry.
Rituxan, a monoclonal antibody used for the treatment of various cancers and autoimmune disorders, continues to witness strong demand. Factors such as increasing prevalence of target diseases, growing adoption of targeted therapies, and favorable reimbursement policies contribute to market growth. Key players in the market are investing in research and development to expand the indications of Rituxan and develop biosimilar versions. Additionally, strategic collaborations and partnerships are facilitating market expansion. However, challenges such as the availability of alternative therapies and the high cost of treatment may limit market growth. Overall, the Rituxan market is expected to exhibit positive growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rituxan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg
Segment by Application
Intravenous Use
Subcutaneous Use
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rituxan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rituxan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rituxan industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rituxan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rituxan introduction, etc. Rituxan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rituxan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices